Mutual of America Capital Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-995
Closed -$140K 1534
2022
Q3
$140K Buy
995
+111
+13% +$20.3K ﹤0.01% 1454
2022
Q2
$180K Buy
884
+129
+17% +$28.2K ﹤0.01% 1367
2022
Q1
$192K Buy
755
+41
+6% +$11.1K ﹤0.01% 1363
2021
Q4
$234K Buy
714
+21
+3% +$6.59K ﹤0.01% 1307
2021
Q3
$210K Sell
693
-1
-0.1% -$284 ﹤0.01% 1337
2021
Q2
$188K Buy
694
+44
+7% +$11.2K ﹤0.01% 1404
2021
Q1
$158K Buy
650
+43
+7% +$11.8K ﹤0.01% 1428
2020
Q4
$174K Buy
607
+17
+3% +$4.68K ﹤0.01% 1328
2020
Q3
$150K Buy
590
+394
+201% +$93.6K ﹤0.01% 1288
2020
Q2
$42K Buy
196
+19
+11% +$4.38K ﹤0.01% 1385
2020
Q1
$40K Buy
177
+36
+26% +$8.88K ﹤0.01% 1340
2019
Q4
$35K Sell
141
-8
-5% -$1.87K ﹤0.01% 1441
2019
Q3
$35K Buy
149
+22
+17% +$5.09K ﹤0.01% 1437
2019
Q2
$31K Buy
+127
New +$29.6K ﹤0.01% 1465

Other funds holding MLAB

Mutual of America Capital Management's MLAB Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 995 shares — an estimated $140K sold.

Mutual of America Capital Management first reported a position in MLAB in Q2 2019 and held it in 14 quarters. The position peaked at $234K in Q4 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

  • Mutual of America Capital Management reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 995 Mesa Laboratories shares in Q4 2022, an estimated $140K.
  • Mutual of America Capital Management first reported a position in Mesa Laboratories in Q2 2019 and held it in 14 quarters.
  • Mutual of America Capital Management's Mesa Laboratories position peaked at $234K in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.